Search Medical Condition
Please enter condition
Please choose location

Eczema (Atopic Dermatitis - Pediatric) Clinical Trials

A listing of Eczema (Atopic Dermatitis - Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (7) clinical trials

Do you or your child suffer from Atopic Dermatitis or Eczema?

Phase

This research study will evaluate the effectiveness and safety of two concentrations (0.5 percent [%] and 1%) and two application frequencies (once a day and twice a day) of GSK2894512 cream for the topical treatment in adolescent and adult subjects with atopic dermatitis (eczema). Results from this study will be ...

Phase

Do you or your child suffer from eczema, also known as atopic dermatitis? Wake Research Associates is enrolling volunteers in a clinical research study testing two, study-related creams to a placebo for individuals with eczema.

Phase N/A

Wake Research Associates is enrolling volunteers with eczema in a clinical research study testing the effectiveness, tolerability and safety of an investigational medication.

Phase N/A

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis

This is a phase 1 and 2 study to assess the safety and efficacy of PAC-14028 cream in children with atopic dermatitis.

Phase

Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis

Objectives: 1. To define the cellular and molecular biomarkers of atopic dermatitis in skin biopsies and blood samples from a pre-adolescent pediatric population and correlate it with disease severity. 2. To measure the skin barrier in atopic dermatitis. 3. To determine quality of life in atopic dermatitis through various questionnaires.

Phase N/A

A Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis

The purpose of this study is to evaluate the safety, tolerability and the pharmacokinetics (PK) of topical INCB018424 cream applied to pediatric subjects (age ≥ 12 to 17 years) with atopic dermatitis (AD).

Phase